AYArrash Yassaee

Arrash Yassaee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arrash Yassaee has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Suitable Evaluation Frameworks for Disease-Agnostic Platforms for Remote Patient Monitoring: Scoping Review

    by Arrash Yassaee, Angus Bruno Reed, Ben Swanson, Ana Luísa Neves, Dougal Hargreaves

    Background: Disease-agnostic platforms (DAPs) are a digital health intervention (DHI) category that can support patients across multiple clinical conditions. While their versatility and configurability can address the fragmentation caused by condition-specific DHIs, DAPs present challenges for evaluation and certification, as they must be assessed across multiple therapeutic areas and diverse applications. A core challenge is identifying suitable evaluation frameworks that can accommodate the highly adaptable nature of this technology. Objective: This review explored whether there are suitable evaluation frameworks for the appraisal and subsequent certification of DAPs, whether any were applied in previous evaluations of DHIs and were available through open access (OA) publications. Methods: Twelve databases (PubMed, Embase, PsycINFO, MEDLINE, Scopus, Web of Science, ACMDL, IEEE Xplore, CINAHL, Cochrane Library, Compendex, and Business Source Complete) were searched on January 28, 2024. Titles, abstracts, and full texts were screened by 1 reviewer, with a minimum 10% sample dual-screened. Inclusion criteria included describing an evaluation framework applied to a DHI. Studies were excluded if there was no novel evaluation framework available to researchers, applicable to digital health evaluation domains, and applicable to a broad patient population. Evaluation frameworks identified were combined with those identified from 5 previous reviews, alongside handsearching and gray literature results. Each framework was assessed against essential and desirable criteria. Essential criteria were applicability across different therapeutic areas and populations, applicability to all domains of digital health, ability to support both formative and summative evaluation, and availability to researchers. Frameworks that met all essential criteria were assessed against desirable criteria, which included presence of operational guidance, evidence of considerations specific to digital health, and incorporation of an evidence assessment method. Results: A total of 40,907 search results contained 72 new frameworks. These were combined with 181 frameworks identified from previous reviews and 1 framework from handsearching and gray literature. Of the 254 frameworks assessed, 15 met all essential criteria, indicating potential suitability for DAP evaluation. One framework, the WHO (World Health Organization) guideline on monitoring and evaluating DHIs, met all desirable criteria. All suitable frameworks had been applied to DHIs and were available in at least 1 OA publication. Conclusions: We found that at least 15 existing frameworks appear suitable for DAP evaluation and can be used to benchmark DAPs against other DHIs. Limitations include potential bias from screening methods and underpinning reviews. Prior use of these frameworks in DHI evaluations and their availability in OA publications enables standardized, high-quality evaluation. Identification of suitable frameworks indicates that research efforts can focus on other outstanding questions related to DAP evaluation, including the acceptable performance benchmark for DAPs, the range of therapeutic areas DAPs need to be favorably evaluated in, and how to synthesize findings across multiple therapeutic areas. Trial Registration: OSF Registries 10.17605/OSF.IO/X578S; https://osf.io/x578s


  • Open Access

    Suitable Evaluation Frameworks for Disease-Agnostic Platforms for Remote Patient Monitoring: Scoping Review (Preprint)

    by Arrash Yassaee, Angus Bruno Reed, Ben Swanson, Ana Luísa Neves, Dougal Hargreaves

    BACKGROUND Disease-agnostic platforms (DAPs) are a digital health intervention (DHI) category that can support patients across multiple clinical conditions. While their versatility and configurability can address the fragmentation caused by condition-specific DHIs, DAPs present challenges for evaluation and certification, as they must be assessed across multiple therapeutic areas and diverse applications. A core challenge is identifying suitable evaluation frameworks that can accommodate the highly adaptable nature of this technology. OBJECTIVE This review explored whether there are suitable evaluation frameworks for the appraisal and subsequent certification of DAPs, whether any were applied in previous evaluations of DHIs and were available through open access (OA) publications. METHODS Twelve databases (PubMed, Embase, PsycINFO, MEDLINE, Scopus, Web of Science, ACMDL, IEEE Xplore, CINAHL, Cochrane Library, Compendex, and Business Source Complete) were searched on January 28, 2024. Titles, abstracts, and full texts were screened by 1 reviewer, with a minimum 10% sample dual-screened. Inclusion criteria included describing an evaluation framework applied to a DHI. Studies were excluded if there was no novel evaluation framework available to researchers, applicable to digital health evaluation domains, and applicable to a broad patient population. Evaluation frameworks identified were combined with those identified from 5 previous reviews, alongside handsearching and gray literature results. Each framework was assessed against essential and desirable criteria. Essential criteria were applicability across different therapeutic areas and populations, applicability to all domains of digital health, ability to support both formative and summative evaluation, and availability to researchers. Frameworks that met all essential criteria were assessed against desirable criteria, which included presence of operational guidance, evidence of considerations specific to digital health, and incorporation of an evidence assessment method. RESULTS A total of 40,907 search results contained 72 new frameworks. These were combined with 181 frameworks identified from previous reviews and 1 framework from handsearching and gray literature. Of the 254 frameworks assessed, 15 met all essential criteria, indicating potential suitability for DAP evaluation. One framework, the WHO (World Health Organization) guideline on monitoring and evaluating DHIs, met all desirable criteria. All suitable frameworks had been applied to DHIs and were available in at least 1 OA publication. CONCLUSIONS We found that at least 15 existing frameworks appear suitable for DAP evaluation and can be used to benchmark DAPs against other DHIs. Limitations include potential bias from screening methods and underpinning reviews. Prior use of these frameworks in DHI evaluations and their availability in OA publications enables standardized, high-quality evaluation. Identification of suitable frameworks indicates that research efforts can focus on other outstanding questions related to DAP evaluation, including the acceptable performance benchmark for DAPs, the range of therapeutic areas DAPs need to be favorably evaluated in, and how to synthesize findings across multiple therapeutic areas. CLINICALTRIAL OSF Registries 10.17605/OSF.IO/X578S; https://osf.io/x578s

  • Open Access

    HEalthRecordBERT (HERBERT): Leveraging Transformers on Electronic Health Records for Chronic Kidney Disease Risk Stratification

    by Alex Moore, Bastien Orset, Arrash Yassaee, Benjamin Irving, Davide Morelli

    Risk stratification is an essential tool in the fight against many diseases, including chronic kidney disease. Recent work has focused on applying techniques from machine learning and leveraging the information contained in a patient’s electronic health record (EHR). Irregular intervals between data entries and the large number of variables tracked in EHR datasets can make them challenging to work with. Many of the difficulties associated with these datasets can be overcome by using large language models, such as bidirectional encoder representations from transformers (BERT). Previous attempts to apply BERT to EHR for risk stratification have shown promise. In this work we propose HERBERT, a novel application of BERT to EHR data. We identify two key areas where BERT models must be modified to adapt them to EHR data, namely: the embedding layer and the pretraining task. We show how changes to these can lead to improved performance, relative to the previous state of the art. We evaluate our model by predicting the transition of chronic kidney disease patients to end stage renal disease. The strong performance of our model justifies our architectural changes and suggests that large language models could play an important role in future renal risk stratification.


  • Open Access

    Engagement With mHealth COVID-19 Digital Biomarker Measurements in a Longitudinal Cohort Study: Mixed Methods Evaluation

    by Kirsten L Rennie, Emma R Lawlor, Arrash Yassaee, Adam Booth, Kate Westgate, Stephen J Sharp, Carina S B Tyrrell, Mert Aral, Nicholas J Wareham

    Background: The COVID-19 pandemic accelerated the interest in implementing mobile health (mHealth) in population-based health studies, but evidence is lacking on engagement and adherence in studies. We conducted a fully remote study for ≥6 months tracking COVID-19 digital biomarkers and symptoms using a smartphone app nested within an existing cohort of adults. Objective: We aimed to investigate participant characteristics associated with initial and sustained engagement in digital biomarker collection from a bespoke smartphone app and if engagement changed over time or because of COVID-19 factors and explore participants’ reasons for consenting to the smartphone substudy and experiences related to initial and continued engagement. Methods: Participants in the Fenland COVID-19 study were invited to the app substudy from August 2020 to October 2020 until study closure (April 30, 2021). Participants were asked to complete digital biomarker modules (oxygen saturation, body temperature, and resting heart rate [RHR]) and possible COVID-19 symptoms in the app 3 times per week. Participants manually entered the measurements, except RHR that was measured using the smartphone camera. Engagement was categorized by median weekly frequency of completing the 3 digital biomarker modules (categories: 0, 1-2, and ≥3 times per week). Sociodemographic and health characteristics of those who did or did not consent to the substudy and by engagement category were explored. Semistructured interviews were conducted with 35 participants who were purposively sampled by sex, age, educational attainment, and engagement category, and data were analyzed thematically; 63% (22/35) of the participants consented to the app substudy, and 37% (13/35) of the participants did not consent. Results: A total of 62.61% (2524/4031) of Fenland COVID-19 study participants consented to the app substudy. Of those, 90.21% (2277/2524) completed the app onboarding process. Median time in the app substudy was 34.5 weeks (IQR 34-37) with no change in engagement from 0 to 3 months or 3 to 6 months. Completion rates (≥1 per week) across the study between digital biomarkers were similar (RHR: 56,517/77,664, 72.77%; temperature: 56,742/77,664, 73.06%; oxygen saturation: 57,088/77,664, 73.51%). Older age groups and lower managerial and intermediate occupations were associated with higher engagement, whereas working, being a current smoker, being overweight or obese, and high perceived stress were associated with lower engagement. Continued engagement was facilitated through routine and personal motivation, and poor engagement was caused by user error and app or equipment malfunctions preventing data input. From these results, we developed key recommendations to improve engagement in population-based mHealth studies. Conclusions: This mixed methods study demonstrated both high initial and sustained engagement in a large mHealth COVID-19 study over a ≥6-month period. Being nested in a known cohort study enabled the identification of participant characteristics and factors associated with engagement to inform future applications in population-based health research.


  • Open Access

    Use of Telemedicine in Pediatric Services for 4 Representative Clinical Conditions: Scoping Review

    by Genevieve Southgate, Arrash A Yassaee, Matthew J Harmer, Helen Livesey, Kate Pryde, Damian Roland

    Background: Telemedicine is becoming routine in health care. Postpandemic, a universal return to face-to-face consultations may risk a loss of some of the advantages of telemedicine. However, rapid implementation and adoption without robust evaluation of usability, efficacy, and effectiveness could potentially lead to suboptimal health outcomes and downstream challenges to providers. Objective: This review assesses telemedicine interventions against international guidance and sufficiency of evidence to support postpandemic utilization in pediatric settings. Methods: This scoping review was performed following searches on PubMed, Embase, and CINAHL databases on April 15, 2021, and May 31, 2022, and examined studies focused on telemedicine, remote consultation, video call, or remote patient monitoring in children (0-18 years) receiving outpatient care for diabetes, asthma, epilepsy, or renal disease. Exclusion criteria included studies published before 2011 as the technologies used have likely been improved or replaced, studies in adult populations or where it was not possible to disaggregate data for participants younger than 18 years as the focus of the review was on pediatric care, and studies not published in English. Data were extracted by 4 authors, and the data were corroborated by a second reviewer. Studies were examined for feasibility and usability, clinical and process outcomes, and cost-effectiveness. Results: Of the 3158 studies identified, 56 were suitable for final inclusion and analysis. Data on feasibility or usability of interventions (48 studies) were overwhelmingly positive in support of telemedicine interventions, with common themes including convenience, perceived cost savings, and ease of use. However, use in preference to usual care was rarely explored. Clinical and process outcome data (31 studies) were mostly positive. Across all studies, there was limited measurement of standardized clinical outcomes, although these were more commonly reported in asthma (peak flow) and diabetes (glycated hemoglobin [HbA1c]). Implementation science data generally supported cost-effectiveness of telemedicine with a reduction of health care costs. Conclusions: There is promising evidence supporting telemedicine in pediatric settings. However, there is a lack of evaluation of telemedicine in comparison with usual outpatient care for noninferiority of clinical outcomes, and this review highlights the need for a more standardized approach to evaluation of digital interventions.


  • Open Access

    Engagement With mHealth COVID-19 Digital Biomarker Measurements in a Longitudinal Cohort Study: Mixed Methods Evaluation (Preprint)

    by Kirsten L Rennie, Emma R Lawlor, Arrash Yassaee, Adam Booth, Kate Westgate, Stephen J Sharp, Carina S B Tyrrell, Mert Aral, Nicholas J Wareham

    BACKGROUND The COVID-19 pandemic accelerated the interest in implementing mobile health (mHealth) in population-based health studies, but evidence is lacking on engagement and adherence in studies. We conducted a fully remote study for ≥6 months tracking COVID-19 digital biomarkers and symptoms using a smartphone app nested within an existing cohort of adults. OBJECTIVE We aimed to investigate participant characteristics associated with initial and sustained engagement in digital biomarker collection from a bespoke smartphone app and if engagement changed over time or because of COVID-19 factors and explore participants’ reasons for consenting to the smartphone substudy and experiences related to initial and continued engagement. METHODS Participants in the Fenland COVID-19 study were invited to the app substudy from August 2020 to October 2020 until study closure (April 30, 2021). Participants were asked to complete digital biomarker modules (oxygen saturation, body temperature, and resting heart rate [RHR]) and possible COVID-19 symptoms in the app 3 times per week. Participants manually entered the measurements, except RHR that was measured using the smartphone camera. Engagement was categorized by median weekly frequency of completing the 3 digital biomarker modules (categories: 0, 1-2, and ≥3 times per week). Sociodemographic and health characteristics of those who did or did not consent to the substudy and by engagement category were explored. Semistructured interviews were conducted with 35 participants who were purposively sampled by sex, age, educational attainment, and engagement category, and data were analyzed thematically; 63% (22/35) of the participants consented to the app substudy, and 37% (13/35) of the participants did not consent. RESULTS A total of 62.61% (2524/4031) of Fenland COVID-19 study participants consented to the app substudy. Of those, 90.21% (2277/2524) completed the app onboarding process. Median time in the app substudy was 34.5 weeks (IQR 34-37) with no change in engagement from 0 to 3 months or 3 to 6 months. Completion rates (≥1 per week) across the study between digital biomarkers were similar (RHR: 56,517/77,664, 72.77%; temperature: 56,742/77,664, 73.06%; oxygen saturation: 57,088/77,664, 73.51%). Older age groups and lower managerial and intermediate occupations were associated with higher engagement, whereas working, being a current smoker, being overweight or obese, and high perceived stress were associated with lower engagement. Continued engagement was facilitated through routine and personal motivation, and poor engagement was caused by user error and app or equipment malfunctions preventing data input. From these results, we developed key recommendations to improve engagement in population-based mHealth studies. CONCLUSIONS This mixed methods study demonstrated both high initial and sustained engagement in a large mHealth COVID-19 study over a ≥6-month period. Being nested in a known cohort study enabled the identification of participant characteristics and factors associated with engagement to inform future applications in population-based health research.

  • Open Access

    SAFEGUARDING SHOULD BE A KEY OUTCOME MEASURE WHEN EVALUATING VIDEO CONSULTATIONS IN PAEDIATRICS

    by Genevieve Southgate, Matthew J Harmer, Rebecca Hewitson, Helen Livesey, Katherine Longbottom, Arrash Yassaee, Damian Roland, Kate Pryde


  • Open Access

    Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study

    by Mohammad A. Dabbah, Angus B. Reed, Adam T.C. Booth, Arrash Yassaee, Alex Despotovic, Benjamin Klasmer, Emily Binning, Mert Aral, David Plans, Alain B. Labrique, et al.

    The COVID-19 pandemic has created an urgent need for robust, scalable monitoring tools supporting stratification of high-risk patients. This research aims to develop and validate prediction models, using the UK Biobank, to estimate COVID-19 mortality risk in confirmed cases. From the 11,245 participants testing positive for COVID-19, we develop a data-driven random forest classification model with excellent performance (AUC: 0.91), using baseline characteristics, pre-existing conditions, symptoms, and vital signs, such that the score could dynamically assess mortality risk with disease deterioration. We also identify several significant novel predictors of COVID-19 mortality with equivalent or greater predictive value than established high-risk comorbidities, such as detailed anthropometrics and prior acute kidney failure, urinary tract infection, and pneumonias. The model design and feature selection enables utility in outpatient settings. Possible applications include supporting individual-level risk profiling and monitoring disease progression across patients with COVID-19 at-scale, especially in hospital-at-home settings.


  • Open Access

    Surveying, shoring, strengthening: rebuilding medical morale from its foundations

    by Arrash Yassaee, Laura Cheetham, Nick Manning-Cork, Cassim Akhoon, Arjun Gowda

    Significant uncertainty surrounds the sustainability of healthcare services in which junior doctors work. It is essential that student and foundation doctors (SFDs) are actively engaged if workforce morale is rebuilt. This narrative review explores the evidence driving the individual work-streams of the Royal College of Physicians' newly formed Student and Foundation Doctor Network. Undergraduate and postgraduate training reform has coincided with concerning feedback from newly qualified doctors. System-level efforts to address this include a focus on extra-contractual matters, where small, sustainable changes could address training and work issues.Fewer foundation year-2 doctors are entering specialty training immediately after the foundation programme. Providing dedicated careers guidance and highlighting opportunities within traditional placements and other career paths can support doctors who undertake non-traditional career routes, including those who take time out of programme.Disseminating these resources through an effective peer-to-peer framework and a well-established mentoring scheme could be the most appropriate way to spread good practice.